DrugsControl Media Services
DrugsControl.org

News Detail

Granules India scolded over truckloads of torn manufacturing documents (20-09-2024)

Maryland, 20 Sept 2024: From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing reprimand from the FDA is alarming no matter which way you look at it.

 

Earlier t......
View Details

Source : Fierce Pharma
Granules India Biocon Gland Pharma ROVI Form 483 U.S. FDA FDA inspection Manufacturing Facilities India Facilities Fierce Pharma Homepage Manufacturing Pharma

Related News